Paloma Geijo

1.0k total citations
20 papers, 566 citations indexed

About

Paloma Geijo is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Paloma Geijo has authored 20 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Small Animals. Recurrent topics in Paloma Geijo's work include Brucella: diagnosis, epidemiology, treatment (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Paloma Geijo is often cited by papers focused on Brucella: diagnosis, epidemiology, treatment (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Paloma Geijo collaborates with scholars based in Spain, United States and Italy. Paloma Geijo's co-authors include Javier Solera, Elisa Martı́nez-Alfaro, Manuel Rodríguez Zapata, Luis Alberto Pomed Sánchez, Marcela Sepúlveda, Elena Navarro, Julio Escribano, M. Maciá, Peré Domingo and Francisco J. Medrano and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Paloma Geijo

19 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paloma Geijo Spain 12 338 308 160 77 67 20 566
Yaşar Bayındır Türkiye 13 158 0.5× 78 0.3× 95 0.6× 22 0.3× 47 0.7× 71 478
Alastair McGregor United Kingdom 14 166 0.5× 174 0.6× 203 1.3× 29 0.4× 15 0.2× 27 762
Marcial Delgado Spain 6 336 1.0× 427 1.4× 53 0.3× 116 1.5× 11 0.2× 9 522
Nurgül Ceran Türkiye 15 239 0.7× 90 0.3× 142 0.9× 24 0.3× 17 0.3× 28 503
Manuel L. Fernández-Guerrero Spain 15 506 1.5× 97 0.3× 246 1.5× 27 0.4× 14 0.2× 37 822
Vuslat Boşnak Türkiye 14 141 0.4× 41 0.1× 54 0.3× 24 0.3× 58 0.9× 35 476
Raul Raz Israel 13 302 0.9× 99 0.3× 113 0.7× 42 0.5× 6 0.1× 20 467
Mehmet Uluğ Türkiye 11 124 0.4× 94 0.3× 69 0.4× 45 0.6× 30 0.4× 39 313
M. Chakroun Tunisia 14 145 0.4× 60 0.2× 215 1.3× 23 0.3× 18 0.3× 77 589
Ali İrfan Baran Türkiye 7 355 1.1× 461 1.5× 109 0.7× 162 2.1× 16 0.2× 27 624

Countries citing papers authored by Paloma Geijo

Since Specialization
Citations

This map shows the geographic impact of Paloma Geijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paloma Geijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paloma Geijo more than expected).

Fields of papers citing papers by Paloma Geijo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paloma Geijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paloma Geijo. The network helps show where Paloma Geijo may publish in the future.

Co-authorship network of co-authors of Paloma Geijo

This figure shows the co-authorship network connecting the top 25 collaborators of Paloma Geijo. A scholar is included among the top collaborators of Paloma Geijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paloma Geijo. Paloma Geijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torralba, Miguel, et al.. (2023). Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain. Annals of Pharmacotherapy. 58(2). 140–147.
2.
Corma‐Gómez, Anaïs, Juan Macı́as, Francisco Téllez, et al.. (2021). Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response. AIDS. 35(13). 2119–2127. 3 indexed citations
3.
4.
Podzamczer, D, Peré Domingo, Celia Miralles, et al.. (2019). Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study. Current HIV Research. 16(6). 425–435. 1 indexed citations
5.
Podzamczer, Daniel, Peré Domingo, Antonio Ocampo, et al.. (2014). ACTG‐HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO‐STR study. Journal of the International AIDS Society. 17(4S3). 19814–19814. 6 indexed citations
6.
Ruiz‐González, Agustín, Miquel Falguera, José M. Porcel, et al.. (2010). C-reactive protein for discriminating treatment failure from slow responding pneumonia. European Journal of Internal Medicine. 21(6). 548–552. 19 indexed citations
7.
Suárez-Lozano, Ignacio, Pompeyo Viciana, Ramón Teira, et al.. (2009). The relationship between antiretroviral prescription patterns and treatment guidelines in treatment‐naïve HIV‐1‐infected patients. HIV Medicine. 10(9). 573–579. 11 indexed citations
8.
Domingo, Peré, Ramón Teira, Fernando Lozano, et al.. (2008). Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort. The Open AIDS Journal. 2(1). 26–38. 21 indexed citations
9.
Teira, Ramón, Ignacio Suárez-Lozano, Pompeyo Viciana, et al.. (2005). Patrón epidemiológico de la infección por el VIH en 15 hospitales españoles: casos de nuevo diagnóstico incluidos en la cohorte VACH en 2001 y 2002. Enfermedades Infecciosas y Microbiología Clínica. 23(4). 213–217. 9 indexed citations
10.
Solera, Javier, Paloma Geijo, Manuel Rodríguez Zapata, et al.. (2004). A Randomized, Double-Blind Study to Assess the Optimal Duration of Doxycycline Treatment for Human Brucellosis. Clinical Infectious Diseases. 39(12). 1776–1782. 44 indexed citations
11.
Roca, Bernardino, Juan González, Myriam Garrido, et al.. (2003). Hepatitis C virus and human immunodeficiency virus coinfection in Spain. Journal of Infection. 47(2). 117–124. 32 indexed citations
12.
Pérez‐Elías, Maria Jesús, Isabel García-Arata, Ignacio de los Santos, et al.. (2003). Phenotype or Virtual Phenotype for Choosing Antiretroviral Therapy after Failure: A Prospective, Randomized Study. Antiviral Therapy. 8(6). 577–584. 36 indexed citations
13.
Suárez-Lozano, Ignacio, Myriam Garrido, Bernardino Roca, et al.. (2002). Epidemiological trends of HIV infection in Spain. AIDS. 16(18). 2496–2499. 19 indexed citations
14.
Martínez, S., Javier Solera, M. Maciá, et al.. (2000). Evaluación de dos pautas de quimioprofilaxis tuberculosa en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica. 115(5). 161–165. 27 indexed citations
15.
Solera, Javier, et al.. (1998). Multivariate model for predicting relapse in human brucellosis. Journal of Infection. 36(1). 85–92. 77 indexed citations
16.
Solera, Javier, Elisa Martı́nez-Alfaro, Luis Alberto Pomed Sánchez, et al.. (1997). Treatment of human brucellosis with doxycycline and gentamicin. Antimicrobial Agents and Chemotherapy. 41(1). 80–84. 70 indexed citations
17.
Solera, Javier, et al.. (1996). Treatment of Human Brucellosis with Netilmicin and Doxycycline. Clinical Infectious Diseases. 22(3). 441–445. 31 indexed citations
18.
Solera, Javier, Manuel Rodríguez Zapata, Paloma Geijo, et al.. (1995). Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrobial Agents and Chemotherapy. 39(9). 2061–2067. 118 indexed citations
19.
Solera, Javier, et al.. (1992). [Brucellar sacroiliitis. A detailed review with an analysis of treatment efficacy].. PubMed. 191(1). 13–8. 5 indexed citations
20.
Solera, Javier, et al.. (1991). [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].. PubMed. 96(17). 649–53. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaşar Bayındır Breakdown of academic impact, for papers by Alastair McGregor Breakdown of academic impact, for papers by Marcial Delgado Breakdown of academic impact, for papers by Nurgül Ceran Breakdown of academic impact, for papers by Manuel L. Fernández-Guerrero Breakdown of academic impact, for papers by Vuslat Boşnak Breakdown of academic impact, for papers by Raul Raz Breakdown of academic impact, for papers by Mehmet Uluğ Breakdown of academic impact, for papers by M. Chakroun Breakdown of academic impact, for papers by Ali İrfan Baran
Rankless by CCL
2026